Benjamin J. Whalley
Benjamin J. Whalley
Verified email at - Homepage
Cited by
Cited by
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
O Devinsky, MR Cilio, H Cross, J Fernandez‐Ruiz, J French, C Hill, ...
Epilepsia 55 (6), 791-802, 2014
Molecular targets of cannabidiol in neurological disorders
CI Bih, T Chen, AVW Nunn, M Bazelot, M Dallas, BJ Whalley
Neurotherapeutics 12 (4), 699-730, 2015
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
NA Jones, AJ Hill, I Smith, SA Bevan, CM Williams, BJ Whalley, ...
Journal of Pharmacology and Experimental Therapeutics 332 (2), 569-577, 2010
Phytocannabinoids as novel therapeutic agents in CNS disorders
AJ Hill, CM Williams, BJ Whalley, GJ Stephens
Pharmacology & therapeutics 133 (1), 79-97, 2012
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro …
FA Iannotti, CL Hill, A Leo, A Alhusaini, C Soubrane, E Mazzarella, ...
ACS chemical neuroscience 5 (11), 1131-1141, 2014
Cannabinoids and epilepsy
EC Rosenberg, RW Tsien, BJ Whalley, O Devinsky
Neurotherapeutics 12 (4), 747-768, 2015
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
NA Jones, SE Glyn, S Akiyama, TDM Hill, AJ Hill, SE Weston, ...
Seizure 21 (5), 344-352, 2012
Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug–Drug Interactions
E Russo, F Scicchitano, BJ Whalley, C Mazzitello, M Ciriaco, S Esposito, ...
Phytotherapy research 28 (5), 643-655, 2014
Molecular pharmacology of phytocannabinoids
SE Turner, CM Williams, L Iversen, BJ Whalley
Phytocannabinoids: unraveling the complex chemistry and pharmacology of …, 2017
Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism
TDM Hill, MG Cascio, B Romano, M Duncan, RG Pertwee, CM Williams, ...
British journal of pharmacology 170 (3), 679-692, 2013
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
EC Rosenberg, PH Patra, BJ Whalley
Epilepsy & Behavior 70, 319-327, 2017
Pharmacological foundations of cannabis chemovars
MA Lewis, EB Russo, KM Smith
Planta medica 84 (04), 225-233, 2018
The proposed mechanisms of action of CBD in epilepsy
RA Gray, BJ Whalley
Epileptic Disorders 22, S10-S15, 2020
Cannabidivarin is anticonvulsant in mouse and rat
AJ Hill, MS Mercier, TDM Hill, SE Glyn, NA Jones, Y Yamasaki, ...
British journal of pharmacology 167 (8), 1629-1642, 2012
Emergence of a small-world functional network in cultured neurons
JH Downes, MW Hammond, D Xydas, MC Spencer, VM Becerra, ...
PLoS computational biology 8 (5), e1002522, 2012
Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
AJ Hill, SE Weston, NA Jones, I Smith, SA Bevan, EM Williamson, ...
Epilepsia 51 (8), 1522-1532, 2010
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
PH Patra, M Barker‐Haliski, HS White, BJ Whalley, S Glyn, H Sandhu, ...
Epilepsia 60 (2), 303-314, 2019
The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway
C Vogl, S Mochida, C Wolff, BJ Whalley, GJ Stephens
Molecular pharmacology 82 (2), 199-208, 2012
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
JA Farrimond, BJ Whalley, CM Williams
Psychopharmacology 223, 117-129, 2012
Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?
JD Wilkinson, BJ Whalley, D Baker, G Pryce, A Constanti, S Gibbons, ...
Journal of Pharmacy and Pharmacology 55 (12), 1687-1694, 2003
The system can't perform the operation now. Try again later.
Articles 1–20